📅Last week, Johan Liseth Hansen from Quantify presented at the Norwegian Health Economics Conference in Oslo.
🔎 His presentation introduced opportunity costs, willingness to pay, and cost-effectiveness thresholds, all key concepts in a fast-evolving public debate in Norway at the moment. We’d […]
📅 On 26 November, Kelsi Smith, Senior Project Lead at Quantify Research, was invited to speak at an online webinar hosted by the Singapore Clinical Research Institute (SCRI) – Generating Real-World Evidence from Real-World […]
This December, our Nordic offices came together in Stockholm to reflect on 2025—and celebrate the year’s end in true julbord spirit.
Before the festivities, both our MAS and RWEA teams held an honest year-in-review:
🍿 What worked well?
🍿 What could improve?
🍿 What we’ll do […]
We’re pleased to welcome Gillian Murphy as a new Research Analyst on our Real World Evidence & Analytics team.
Gillian completed her Master’s in Epidemiology at Karolinska Institutet in 2022, and since then has deepened her expertise as a Research Assistant […]
We’re excited to welcome Ankit Gupta to the Quantify team as an Assistant Manager in our Evidence Review & Synthesis (ERS) function.
Ankit brings valuable experience from his previous role at Lumanity as a Senior Research Associate. With a Master’s in […]
Last week, Quantify’s Head of RWE and Analytics Emilie Toresson Grip were invited to join 70+ leaders from healthcare, academia, and industry to the Swelife High-Level Meeting. The meeting aimed to discuss concrete solutions to health data challenges in Sweden in the […]
On her way into the office, one of our colleagues captured this view: Stockholm at dawn, river reflections, lights still glowing.
A calm start to a busy week.
At Quantify Research, clarity often comes in quiet moments.
Behind every analysis is intent. Behind […]
🩺 Real‑world diabetes research—done right
From risk prediction in metabolic syndrome to cost comparisons in insulin delivery, diabetes care needs rigour, relevance, and real‑world insight.
🔹 In 2024, we helped show how metabolic syndrome traits raise the risk of liver outcomes in […]
💬 Thank you, ISPOR—The Professional Society for Health Economics and Outcomes Research for the posters, panels, and perspectives
Our team returns from ISPOREurope full of insights and gratitude.
■ Gratitude for the collaborative conversations, the thought-provoking […]
Managed Entry Agreements (MEAs) are important tools for reimbursement across Sweden, Norway, Denmark, and Finland – especially in areas such as oncology, rare diseases and precision medicine. While their use is growing, the pathways and requirements differ substantially between countries.
From […]